Monday, September 20

biofármaco

biofármaco, científica mexicana, coronavirus, Covid 19, farmaco, Mexico, Noticias, Paola Castillo Juárez, Salud, Variante Delta

Mexicana develops biopharmaceutical to combat COVID-19 | Digital Trends Spanish

Paola Castillo Juárez, a scientist at the National Polytechnic Institute of Mexico (IPN), developed a biopharmaceutical that can be highly effective in combating COVID-19. This biopharmaceutical was developed from the design of four peptides, defined as small protein fragments, which have an efficacy of over 90 percent against the replication of COVID-19, once they are synthesized. The virology expert also highlighted that peptides are evaluated at the National Institute of Respiratory Diseases (INER) directly with the coronavirus isolated from patients. IPN."The results are surprising because the molecules developed focus on conserved sequences of the parts of the SARS-CoV-2 protein, which do not change even when the virus mutates and gives rise to new variants," explained the scientis...